CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 16 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,342 | -41.7% | 183 | -49.9% | 0.00% | – |
| Q2 2023 | $5,731 | +114520.0% | 365 | +18.9% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 307 | -17.3% | 0.00% | – |
| Q3 2022 | $6,000 | -25.0% | 371 | -18.1% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 453 | +4.9% | 0.00% | – |
| Q1 2022 | $8,000 | -38.5% | 432 | -18.2% | 0.00% | – |
| Q4 2021 | $13,000 | – | 528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 750,000 | $13,695,000 | 0.37% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 26,688 | $487,323 | 0.30% |
| SPHERA FUNDS MANAGEMENT LTD. | 11,863 | $216,618 | 0.04% |
| Nalls Sherbakoff Group, LLC | 35 | $640 | 0.00% |
| DEUTSCHE BANK AG\ | 90,550 | $1,653,443 | 0.00% |
| Citadel Advisors | 2,700 | $49,302 | 0.00% |
| Citadel Advisors | 5,500 | $100,430 | 0.00% |
| Citadel Advisors | 4,958 | $90,533 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22,100 | $403,546 | 0.00% |
| SIMPLEX TRADING, LLC | 536 | $9 | 0.00% |